Kawahara M - Search Results

1

Phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in patients with unresectable stage III non-small-cell lung cancer: West Japan Thoracic Oncology Group WJTOG0105.

Yamamoto N, Nakagawa K, Nishimura Y, Tsujino K, Satouchi M, Kudo S, Hida T, Kawahara M, Takeda K, Katakami N, Sawa T, Yokota S, Seto T, Imamura F, Saka H, Iwamoto Y, Semba H, Chiba Y, Uejima H, Fukuoka M. Yamamoto N, et al. Among authors: kawahara m. J Clin Oncol. 2010 Aug 10;28(23):3739-45. doi: 10.1200/JCO.2009.24.5050. Epub 2010 Jul 12. J Clin Oncol. 2010. PMID: 20625120 Clinical Trial.

2

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer.

Noda K, Nishiwaki Y, Kawahara M, Negoro S, Sugiura T, Yokoyama A, Fukuoka M, Mori K, Watanabe K, Tamura T, Yamamoto S, Saijo N; Japan Clinical Oncology Group. Noda K, et al. Among authors: kawahara m. N Engl J Med. 2002 Jan 10;346(2):85-91. doi: 10.1056/NEJMoa003034. N Engl J Med. 2002. PMID: 11784874 Free article. Clinical Trial.

3

A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer.

Atagi S, Kawahara M, Hosoe S, Ogawara M, Kawaguchi T, Okishio K, Naka N, Sunami T, Mitsuoka S, Akira M. Atagi S, et al. Among authors: kawahara m. Lung Cancer. 2002 Apr;36(1):105-11. doi: 10.1016/s0169-5002(01)00460-3. Lung Cancer. 2002. PMID: 11891041 Clinical Trial.

4

A feasibility study of paclitaxel 225 mg/m(2) and carboplatin AUC = 6 in untreated advanced non-small cell lung cancer patients in Japan.

Ogawara M, Kawahara M, Hosoe S, Atagi S, Kawaguchi T, Okishio K, Naka N, Sunami T, Mitsuoka S, Inoue K, Haryu H, Yoneda T, Origasa H. Ogawara M, et al. Among authors: kawahara m. Jpn J Clin Oncol. 2002 Feb;32(2):48-53. doi: 10.1093/jjco/hyf014. Jpn J Clin Oncol. 2002. PMID: 11948228 Clinical Trial.

5

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.

Takada M, Fukuoka M, Kawahara M, Sugiura T, Yokoyama A, Yokota S, Nishiwaki Y, Watanabe K, Noda K, Tamura T, Fukuda H, Saijo N. Takada M, et al. Among authors: kawahara m. J Clin Oncol. 2002 Jul 15;20(14):3054-60. doi: 10.1200/JCO.2002.12.071. J Clin Oncol. 2002. PMID: 12118018 Clinical Trial.

6

Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer.

Naka N, Kawahara M, Okishio K, Hosoe S, Ogawara M, Atagi S, Takemoto Y, Ueno K, Kawaguchi T, Tsuchiyama T, Furuse K. Naka N, et al. Among authors: kawahara m. Lung Cancer. 2002 Sep;37(3):319-23. doi: 10.1016/s0169-5002(02)00073-9. Lung Cancer. 2002. PMID: 12234702 Clinical Trial.

7

The impact of residual multi-level N2 disease after induction therapy for non-small cell lung cancer.

Sawabata N, Keller SM, Matsumura A, Kawashima O, Hirono T, Osaka Y, Maeda H, Fukai S, Kawahara M; Japan National Chest Hospital Study Group for Lung Cancer. Sawabata N, et al. Among authors: kawahara m. Lung Cancer. 2003 Oct;42(1):69-77. doi: 10.1016/s0169-5002(03)00245-9. Lung Cancer. 2003. PMID: 14512190

8

Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung.

Kato H, Furukawa K, Sato M, Okunaka T, Kusunoki Y, Kawahara M, Fukuoka M, Miyazawa T, Yana T, Matsui K, Shiraishi T, Horinouchi H. Kato H, et al. Among authors: kawahara m. Lung Cancer. 2003 Oct;42(1):103-11. doi: 10.1016/s0169-5002(03)00242-3. Lung Cancer. 2003. PMID: 14512194 Clinical Trial.

9

[Lung toxicity of trimodality chemoradiotherapy with mitomycin C, vindesine, and cisplatin followed by surgery for locally advanced non-small cell lung cancer].

Sawa T, Yoshida T, Ishiguro T, Ogawara M, Kawahara M, Yamamoto S, Yokota S, Maeda H, Asamoto H. Sawa T, et al. Among authors: kawahara m. Gan To Kagaku Ryoho. 2003 Oct;30(11):1745-9. Gan To Kagaku Ryoho. 2003. PMID: 14619509 Japanese.

10

A phase II study of topotecan in patients with relapsed small-cell lung cancer.

Takeda K, Negoro S, Sawa T, Nakagawa K, Kawahara M, Isobe T, Kudoh S, Masuda N, Niitani H, Fukuoka M. Takeda K, et al. Among authors: kawahara m. Clin Lung Cancer. 2003 Jan;4(4):224-8. doi: 10.3816/clc.2003.n.002. Clin Lung Cancer. 2003. PMID: 14624710

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

915 results

Search Page

Filters